Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series

Regina Berkovich1, Jonathan Calkwood2, Heidi Crayton3

  • 1Regina Berkovich MD, PhD Inc (MS Center and Research Institute), West Hollywood, CA, United States.

PubMed

[This corrects the article DOI: 10.3389/fimmu.2025.1527102.].

Related Concept Videos